Newsroom | 1468 results

SAN FRANCISCO--(BUSINESS WIRE)--Powered by Forager® AI from discovery to market, Brightseed Launches BioMetaControl™, a Nature-Inspired GLP-1 Companion for Metabolic Health....

DUBLIN--(BUSINESS WIRE)--The "Health and Wellness Market - Preventive Care & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. Health and Wellness Market is projected to become US$ 4.81 trillion by 2033, from US$ 3.52 trillion in 2024, with a CAGR of 3.55% from 2025 to 2033. This surge is fueled by rising consumer knowledge regarding preventive care, increased demand for organic and natural products, and advanced technology in fitness, nutrition, and mental wel...

LONDON--(BUSINESS WIRE)--Closed Loop Medicine Ltd (CLM), a leader in personalized pharmaceutical dosing, today announced the U.S. launch of WeDosify, which enables clinicians to personalize GLP-1 titration at scale. The launch comes as the global anti-obesity market, valued at over $30 billion in 2024, is projected to reach $100 billion by 2030. Despite this growth, GLP-1 therapies face a major real-world challenge: up to 44% of patients discontinue treatment within six months, with that figure...

MONTVALE, N. J.--(BUSINESS WIRE)--Balchem, a global manufacturer of specialty ingredients for human nutrition, has launched its first direct-to-consumer initiative....

AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (Ollin), a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases, today announced its launch with an initial $100 million in financing led by ARCH Venture Partners, Mubadala Capital and Monograph Capital. Ollin is assembling a robust pipeline of both clinical and late-stage preclinical programs, building upon validated biologies to better address unmet treat...

CHICAGO--(BUSINESS WIRE)--ClostraBio, Inc., a biotech company pioneering microbiome-based solutions for gastrointestinal health, today announced two major milestones: the appointment of Scott Ravech, former CEO of Deerland Probiotics & Enzymes, to its Board of Directors, and the peer-reviewed publication of toxicology data validating the safety of its lead ingredient, Anaerostipes caccae CLB101™. These achievements set the stage for the company’s commercial launch later this month with a le...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today unveils the newly evolved AboutNADⓇ, a centralized educational resource and published research database detailing scientific advancements in NAD+ biology and its role in human health. Guided by the mission of empowering health through scientific education, the new and improved site distills peer-reviewed findin...

CHANGWON, South Korea--(BUSINESS WIRE)--Wellness Innercell utilizes its experience in the U.S. market and aims to broaden its international consumer base....

シンガポール--(BUSINESS WIRE)--（ビジネスワイヤ） -- タンパク質およびプレバイオティクスの世界的リーダーであるフリースランド・カンピーナ・イングリーディエンツ（FrieslandCampina Ingredients）は、このたびシンガポールに新たなアプリケーションセンターを開設したことを発表しました。この開設により、同国におけるR&Dスペースは30%拡大することとなります。同施設はシンガポール経済開発庁（EDB）の支援を受けており、日本、韓国、オーストラリア、ニュージーランド、東南アジアを含む、変化を遂げているアジア太平洋（APAC）市場への戦略的ゲートウェイとして機能します。拡張されたアプリケーションセンターは、シンガポールが同社にとって重要な地域本部であることを改めて示すだけでなく、地域の多様かつ拡大する栄養ニーズに応えるため、ブランド向けにカスタマイズされた原料ソリューションをより迅速に提供できるようにします。シンガポールには、フリースランド・カンピーナ・プロフェッショナル（FrieslandCampina Professional）やフリースラ...

新加坡--(BUSINESS WIRE)--(美國商業資訊)-- 蛋白質和益生元領域的全球領導者FrieslandCampina Ingredients宣布在新加坡設立新的應用中心，使該公司在新加坡的研發空間增加了30%。在新加坡經濟發展局(EDB)的支援下，該設施將成為針對不斷發展的亞太市場（包括日本、韓國、澳洲、紐西蘭和東南亞）的策略門戶。新擴建的應用中心不僅重申了新加坡做為公司重要地區總部的地位，還有助於更快地提供客製化配料解決方案，協助品牌滿足該地區多樣化且不斷成長的營養需求。新加坡也是FrieslandCampina其他業務集團的所在地，包括FrieslandCampina Professional和FrieslandCampina Asia，彰顯了公司對該市場的長期承諾。 推動以亞太為中心的創新 由於亞太地區五分之四的消費者積極服用營養補充品1，該地區不斷成長的需求為以消費者為中心的應用開發提供了巨大商機。新的應用中心強化了FrieslandCampina Ingredients在亞太地區的實地應用和技術專長，以滿足這一需求。該中心配備了先進的實驗室，用於開發優格、能量棒和...